X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 28/Feb 14:36

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus

XENE reports a narrower-than-expected fourth-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.

Articles similaires

Sorry! Image not available at this time

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

zacks.com - 28/Feb 18:26

RCKT incurs a narrower-than-expected fourth-quarter 2024 loss. The company provides updates on its pipeline candidates.

Sorry! Image not available at this time

NTLA's Q4 Loss Narrower Than Estimates, Revenues Increase Y/Y

zacks.com - 28/Feb 18:24

Intellia reports better-than-expected fourth-quarter 2024 results. The company provides updates on its pipeline candidates.

Sorry! Image not available at this time

Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus

zacks.com - 28/Feb 18:12

KYMR reports a wider-than-expected loss for the fourth quarter of 2024. The company expects the current cash balance to provide a runway into...

Sorry! Image not available at this time

Beam Therapeutics' Q4 Earnings & Revenues Beat Estimates

zacks.com - 26/Feb 15:42

BEAM incurs a narrower-than-expected loss in the fourth quarter. The company remains focused on pipeline development.

Sorry! Image not available at this time

EVgo Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

zacks.com - 14:46

EVGO's fourth-quarter 2024 results reflect a narrower loss, 35% revenue growth YoY and a significant boost in charging network revenues.

Sorry! Image not available at this time

Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus

zacks.com - 28/Feb 18:14

DNLI reports a narrower-than-expected loss for the fourth quarter of 2024. Denali remains on track to submit a BLA for tividenofusp alfa for the...

Sorry! Image not available at this time

EYE Q4 Loss Narrower Than Expected, Margins Rise, Stock Surges

zacks.com - 27/Feb 13:31

Continued strength in Managed Care aids National Vision's fourth-quarter 2024 performance.

Sorry! Image not available at this time

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus

zacks.com - 20/Feb 16:15

IONS reports better-than-expected top and bottom-line numbers for the fourth quarter.

Sorry! Image not available at this time

Advance Auto Q4 Loss Narrower Than Expected, Revenues Decline Y/Y

zacks.com - 26/Feb 15:36

AAP reports a narrower-than-expected Q4 loss and expects 2025 net sales from continuing operations in the range of $8.4-$8.6 billion.

Sorry! Image not available at this time

Sarepta Q4 Earnings Lag Estimates, Revenues Gain on Gene Therapy Sales

zacks.com - 27/Feb 13:45

SRPT reports mixed fourth-quarter 2024 results. It closes the multi-billion-dollar deal with Arrowhead and adds four new clinical programs to its...